Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) just unveiled an update.
Lifecare ASA has completed the allocation in its partially underwritten rights issue, setting the final size at 160 million new shares, which will raise NOK 80 million in gross proceeds, fully subscribed within the announced minimum range. Existing shareholders subscribed both on the basis of subscription rights and through oversubscription, while underwriters were allocated 17.15 million shares under their guarantee commitments and will be compensated with a mix of cash or shares and additional warrants. In connection with the transaction, investors will receive a total of about 240 million free warrants in two 2026 exercise windows, potentially providing Lifecare with up to a further NOK 150 million in capital if fully exercised, while the new shares are expected to start trading on Euronext Oslo Børs on 28 January 2026, strengthening the company’s funding base and liquidity for its ongoing operations.
More about Lifecare AS
Lifecare ASA is a Norway-based listed company, with its shares traded on Euronext Oslo Børs, and is engaged in the development and commercialisation of medical technology solutions, positioning itself within the broader healthcare and life sciences investment universe.
Average Trading Volume: 542,265
Current Market Cap: NOK157.7M
For an in-depth examination of LFC0 stock, go to TipRanks’ Overview page.